CFD'er er komplekse instrumenter, og der er stor risiko for at miste penge hurtigt på grund af gearing. 84% af individuelle investorer taber penge, når de handler CFD'er med denne udbyder. Du bør overveje, om du forstår, hvordan CFD'er virker, og om du har råd til at løbe en høj risiko for at miste dine penge.

Handel Soligenix, Inc. - SNGX CFD

1.914
4.92%
  • Opsummering
  • Historisk Data
  • Begivenheder
  • Resultatopgørelse
  • Saldo
  • Cash flow
  • Ejerskab
Handelsbetingelser
Spænd 0.122
Long position, gebyr natten over

Long position overnight fee


Margin. Your investment $1,000.00
Gebyr for natten over -0.024874 %
Charges from borrowed part ($-0.99)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Gå til platform
-0.024874%
Short position, gebyr natten over

Short position overnight fee


Margin. Your investment $1,000.00
Gebyr for natten over 0.002651 %
Charges from borrowed part ($0.11)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Gå til platform
0.002651%
Gebyr natten over, tid 21:00 (UTC)
Min. handlet mængde 1
Valuta USD
Margen 20%
Aktiebørs United States of America
Kommission på handel 0%

*Information provided by Capital.com

Nøglestatistikker
Tidligere luk* 2.013
Åben* 2.003
1-Års Ændring* 186.96%
Dagens Spænd* 1.824 - 2.003
52-Ugers Spænd 1.75-15.00
Gennemsnitlig Volumen (10 dage) 26.42K
Gennemsnitlig Volumen (3 måneder) 600.02K
Market Cap 5.92M
P/E-forhold -100.00K
Udestående aktier 2.89M
Omsætning 858.49K
EPS -5.15
Dividend (Udbytte %) N/A
Beta 1.79
Næste indtjeningsopgørelse May 11, 2023

Al data kommer fra Refinitiv, med undtagelse af data markeret med en asterisk, som er *data fra Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Luk Change Change (%) Åben High Low
Mar 31, 2023 1.914 -0.089 -4.44% 2.003 2.003 1.824
Mar 30, 2023 2.013 -0.260 -11.44% 2.273 2.273 1.963
Mar 29, 2023 2.143 0.000 0.00% 2.143 2.143 2.143
Mar 28, 2023 1.944 0.080 4.29% 1.864 1.993 1.864
Mar 27, 2023 1.854 -0.050 -2.63% 1.904 1.904 1.794
Mar 24, 2023 1.764 -0.010 -0.56% 1.774 1.774 1.764
Mar 23, 2023 1.744 -0.200 -10.29% 1.944 1.944 1.744
Mar 22, 2023 1.774 -0.229 -11.43% 2.003 2.013 1.774
Mar 21, 2023 2.043 -0.160 -7.26% 2.203 2.203 2.013
Mar 20, 2023 2.133 -0.070 -3.18% 2.203 2.273 2.093
Mar 17, 2023 2.312 -0.180 -7.22% 2.492 2.492 2.123
Mar 16, 2023 2.492 -0.189 -7.05% 2.681 2.751 2.492
Mar 15, 2023 2.701 -0.020 -0.74% 2.721 2.831 2.701
Mar 14, 2023 2.761 -0.110 -3.83% 2.871 2.891 2.731
Mar 13, 2023 2.831 -0.129 -4.36% 2.960 2.970 2.831
Mar 10, 2023 3.030 0.090 3.06% 2.940 3.030 2.940
Mar 9, 2023 3.090 0.299 10.71% 2.791 3.150 2.791
Mar 8, 2023 2.741 0.020 0.74% 2.721 2.821 2.721
Mar 7, 2023 2.801 -0.060 -2.10% 2.861 2.861 2.801
Mar 6, 2023 2.950 -0.020 -0.67% 2.970 2.970 2.950

Soligenix, Inc. Events

Tid (UTC) (UTC) Land Begivenhed
No events scheduled
Se alle begivenheder
  • Årlig
  • Pr kvartal
2021 2020 2019 2018 2017
Total omsætning 0.82427 2.35945 4.62992 5.24145 5.43247
Omsætning 0.82427 2.35945 4.62992 5.24145 5.43247
Kost af omsætning, Total 0.72864 1.82095 3.56742 4.59772 4.31008
Bruttofortjeneste 0.09563 0.5385 1.0625 0.64373 1.12239
Totale Driftsudgifter 13.5436 20.9459 15.1709 14.3004 13.0263
Salgs/Generelle/Admin. Udgifter, Total 4.84713 3.97923 3.48091 2.95176 3.20916
Forskning & Udvikling 8.38939 15.1458 8.12261 6.75095 5.50703
Usædvanlig Udgift (Indkomst) -0.42158 0
Driftsindtægter -12.7193 -18.5865 -10.541 -9.05898 -7.5938
Renteindkomst (Udgift), Netto Ikke-Drift -0.90194 -0.03427 0.14116 0.15901 0.02991
Netto Indkomst Før Skat -13.4157 -18.5254 -9.96627 -8.89998 -7.56389
Netto Indkomst Efter Skat -12.551 -17.6885 -9.35559 -8.89998 -7.14708
Netto Indkomst Før Ekstra Ting -12.551 -17.6885 -9.35559 -8.89998 -7.14708
Netto Indkomst -12.551 -17.6885 -9.35559 -8.89998 -7.14708
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting -12.551 -17.6885 -9.35559 -8.89998 -7.14708
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting -12.551 -17.6885 -9.35559 -8.89998 -7.14708
Fortyndet Netto Indkomst -12.551 -17.6885 -9.35559 -8.89998 -7.14708
Fortyndet Vægtet Gennemsnit Aktier 2.67561 1.83255 1.29183 0.87859 0.40964
Fortyndet EPS Uden Ekstraordinære Ting -4.69088 -9.65238 -7.24211 -10.1299 -17.4474
Fortyndet Normaliseret EPS -4.7933 -9.65238 -7.24211 -10.1299 -17.4474
Totale Ekstraordinære Ting 0
Andre, Netto 0.20552 0.09536 0.43359
Sep 2022 Jun 2022 Mar 2022 Dec 2021 Sep 2021
Total omsætning 0.16614 0.22864 0.18806 0.27565 0.1862
Omsætning 0.16614 0.22864 0.18806 0.27565 0.1862
Kost af omsætning, Total 0.12944 0.1933 0.09221 0.2357 0.16627
Bruttofortjeneste 0.0367 0.03534 0.09585 0.03995 0.01993
Totale Driftsudgifter 3.24738 3.62394 4.39069 4.7979 3.56158
Salgs/Generelle/Admin. Udgifter, Total 1.32625 1.38279 2.55171 2.12639 0.91402
Forskning & Udvikling 1.7917 2.04784 1.74677 2.43582 2.4813
Driftsindtægter -3.08124 -3.3953 -4.20263 -4.52225 -3.37538
Renteindkomst (Udgift), Netto Ikke-Drift -0.22776 -0.12001 -0.30976 -0.2345 -0.28377
Andre, Netto 0 -0.02639 0.16337 0.05287 0.0716
Netto Indkomst Før Skat -3.309 -3.5417 -4.34902 -4.70388 -3.58755
Netto Indkomst Efter Skat -3.309 -2.38676 -4.34902 -4.70388 -3.58755
Netto Indkomst Før Ekstra Ting -3.309 -2.38676 -4.34902 -4.70388 -3.58755
Netto Indkomst -3.309 -2.38676 -4.34902 -4.70388 -3.58755
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting -3.309 -2.38676 -4.34902 -4.70388 -3.58755
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting -3.309 -2.38676 -4.34902 -4.70388 -3.58755
Fortyndet Netto Indkomst -3.309 -2.38676 -4.34902 -4.70388 -3.58755
Fortyndet Vægtet Gennemsnit Aktier 2.87239 2.86762 2.86148 2.85986 2.71333
Fortyndet EPS Uden Ekstraordinære Ting -1.152 -0.83231 -1.51985 -1.64479 -1.3222
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Fortyndet Normaliseret EPS -1.152 -0.83231 -1.51985 -1.64479 -1.3222
Usædvanlig Udgift (Indkomst) 0 0 0 0
  • Årlig
  • Pr kvartal
2021 2020 2019 2018 2017
Totale Nuværende Aktiver 26.5695 19.467 7.49333 10.3427 9.4158
Likvider og Kortsigtede Investeringer 26.0439 18.6767 5.42071 8.98372 7.80949
Likvider & Lignende 26.0439 18.6767 5.42071 8.98372 7.80949
Totale Tilgodehavender, Netto 0.24272 0.56487 1.46288 1.20172 1.34306
Accounts Receivable - Trade, Net 0.13889 0.20377 1.01884 1.20172 0.92625
Prepaid Expenses 0.2829 0.22547 0.60974 0.15728 0.26325
Total Assets 26.8699 19.8912 7.77536 10.4917 9.54965
Property/Plant/Equipment, Total - Net 0.12838 0.25154 0.16151 0.01963 0.03716
Intangibles, Net 0 0.0197 0.04686 0.07395
Total Current Liabilities 6.29118 6.08052 6.31208 4.21153 3.22994
Accounts Payable 2.92554 2.12984 2.73544 2.12622 1.75361
Accrued Expenses 3.36563 3.6257 3.57663 2.08532 1.47633
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total
Total Liabilities 16.1473 16.1494 6.31823 4.21153 3.22994
Total Long Term Debt 9.85615 9.95259 0 0 0
Total Equity 10.7226 3.74183 1.45714 6.28017 6.31971
Common Stock 0.04287 0.03064 0.02175 0.01768 0.00873
Additional Paid-In Capital 216.403 196.95 177.006 172.436 163.581
Retained Earnings (Accumulated Deficit) -205.765 -193.214 -175.526 -166.17 -157.27
Total Liabilities & Shareholders’ Equity 26.8699 19.8912 7.77536 10.4917 9.54965
Total Common Shares Outstanding 42.8735 30.6437 21.7531 17.6828 8.73064
Other Long Term Assets, Total 0.17203 0.17269 0.10083 0.0825 0.02273
Other Equity, Total 0.04194 -0.02434 -0.04501 -0.00367
Other Liabilities, Total 0 0.1163 0.00615
Current Port. of LT Debt/Capital Leases 0 0.32498
Long Term Debt 9.85615 9.95259
Property/Plant/Equipment, Total - Gross 0.19007
Accumulated Depreciation, Total -0.16785
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Totale Nuværende Aktiver 23.4742 26.5695 29.4445 29.3528 31.2803
Likvider og Kortsigtede Investeringer 22.8757 26.0439 28.8675 28.98 30.5419
Likvider & Lignende 22.8757 26.0439 28.8675 28.98 30.5419
Totale Tilgodehavender, Netto 0.24493 0.24272 0.14796 0.22428 0.26754
Accounts Receivable - Trade, Net 0.12369 0.13889 0.04418 0.11768 0.16172
Prepaid Expenses 0.35364 0.2829 0.42909 0.14859 0.47086
Total Assets 23.6746 26.8699 29.7178 29.6103 31.5525
Property/Plant/Equipment, Total - Net 0.10292 0.12838 0.15042 0.18485 0.21852
Property/Plant/Equipment, Total - Gross 0.19989 0.19007 0.17828 0.17828 0.17828
Accumulated Depreciation, Total -0.1722 -0.16785 -0.16418 -0.16104 -0.15793
Other Long Term Assets, Total 0.09748 0.17203 0.12284 0.0726 0.05364
Total Current Liabilities 7.22375 6.29118 4.79563 4.12471 4.3007
Accounts Payable 4.51817 2.92554 1.90578 1.48236 1.34036
Accrued Expenses 2.70558 3.36563 2.88985 2.64235 2.56572
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 0 0 0 0.39462
Total Liabilities 17.0902 16.1473 14.6633 14.0141 14.2339
Total Long Term Debt 9.8664 9.85615 9.84568 9.83521 9.8476
Long Term Debt 9.8664 9.85615 9.84568 9.83521 9.8476
Other Liabilities, Total 0 0.02194 0.05418 0.08563
Total Equity 6.5845 10.7226 15.0545 15.5962 17.3186
Common Stock 0.04295 0.04287 0.04263 0.04008 0.04002
Additional Paid-In Capital 216.531 216.403 216.024 213.062 212.891
Retained Earnings (Accumulated Deficit) -210.114 -205.765 -201.061 -197.474 -195.577
Other Equity, Total 0.12459 0.04194 0.04956 -0.03206 -0.03568
Total Liabilities & Shareholders’ Equity 23.6746 26.8699 29.7178 29.6103 31.5525
Total Common Shares Outstanding 42.9541 42.8735 42.6304 40.0788 40.0205
  • Årlig
  • Pr kvartal
2021 2020 2019 2018 2017
Netto indkomst/Startlinje -12.551 -17.6885 -9.35559 -8.89998 -7.14708
Likvider Fra Driftsaktiviteter -11.7396 -11.4544 -7.50957 -7.24463 -6.51057
Likvider Fra Driftsaktiviteter 0.03416 0.06237 0.05445 0.04406 0.06856
Ikke-Likvide Ting 0.12569 5.66242 0.65484 0.38237 0.49571
Cash Taxes Paid 0.00773 0.00402 0.01113 0.00258 0.00508
Ændringer i Driftskapital 0.6515 0.50931 1.13673 1.22892 0.07224
Likvider fra Investeringsaktiviteter -0.01179 -0.00715 -0.02471 -0.00093 -0.02635
Kapitaludgifter -0.01179 -0.00715 -0.03021 -0.00193 -0.02635
Likvider fra Financieringsaktiviteter 19.058 24.6766 4.00546 8.42346 5.57384
Financiering af Cash-Flow-Ting -0.66741 -0.79773 -0.13208 -0.25189 -0.67236
Udstedelse (Pensionering) af Aktier, Netto 19.7316 15.0641 4.14434 8.67535 6.2462
Udstedelse (Pensionering) af Gæld, Netto -0.00615 10.4103 -0.0068
Netto Ændring i Likviditet 7.36723 13.256 -3.56301 1.17423 -0.96308
Andre Investerings-Cash-Flow-Ting, Total 0.0055 0.001
Udenlandsk Børs Effekter 0.06064 0.04088 -0.03419 -0.00367
Likvid Rente Betalt 0.66872 0.03441
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Net income/Starting Line -4.34902 -12.551 -7.8471 -4.25955 -2.36248
Cash From Operating Activities -3.23884 -11.7396 -8.68427 -5.64415 -3.98523
Cash From Operating Activities 0.00823 0.03416 0.02661 0.01774 0.0089
Non-Cash Items 0.16944 0.12569 -0.02136 -0.16847 0.13296
Cash Taxes Paid 0 0.00773 0.00738 0.00738 0.00213
Changes in Working Capital 0.93251 0.6515 -0.84243 -1.23387 -1.7646
Cash From Investing Activities -0.00982 -0.01179 0 0 0
Capital Expenditures -0.00982 -0.01179 0 0 0
Cash From Financing Activities 0 19.058 18.8072 15.9444 15.8557
Financing Cash Flow Items 0 -0.66741 -0.62985 -0.54196 -0.53796
Issuance (Retirement) of Stock, Net 0 19.7316 19.4432 16.4904 16.3957
Issuance (Retirement) of Debt, Net 0 -0.00615 -0.00615 -0.00405 -0.002
Foreign Exchange Effects 0.08045 0.06064 0.06791 0.00308 -0.00519
Net Change in Cash -3.16822 7.36723 10.1908 10.3033 11.8653
Cash Interest Paid 0.2239 0.66872 0.44481 0.44481
Investornavn Investortype Procent udestående Aktiebeholdning Aktieændring Beholdningsdato IOmsætningsscore
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 3.7868 109402 52 2022-12-31 LOW
First Wilshire Securities Management, Inc. Investment Advisor/Hedge Fund 0.8076 23333 0 2022-12-31 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.7493 21647 -52 2022-12-31 LOW
Schaber (Christopher J) Individual Investor 0.2079 6006 0 2023-01-05 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 0.1684 4864 0 2022-12-31 LOW
Plante Moran Financial Advisors, LLC Investment Advisor 0.1654 4777 0 2022-12-31 LOW
IHT Wealth Management, LLC Investment Advisor 0.1619 4677 0 2022-12-31 LOW
Renaissance Technologies LLC Hedge Fund 0.1574 4547 94 2022-12-31 HIGH
Citadel Advisors LLC Hedge Fund 0.1477 4268 4268 2022-12-31 HIGH
Northern Trust Investments, Inc. Investment Advisor/Hedge Fund 0.1339 3869 0 2022-12-31 LOW
Mahrberg Wealth AG Investment Advisor 0.1154 3333 3333 2021-12-31 LOW
ARGI Investment Services, LLC Investment Advisor 0.1081 3122 0 2022-12-31 LOW
Fiduciary Trust Company Bank and Trust 0.0942 2721 0 2022-12-31 LOW
Stewart Capital Advisors, LLC Investment Advisor 0.0881 2545 0 2022-12-31 LOW
BNY Mellon Asset Management Investment Advisor 0.0595 1720 0 2022-12-31 LOW
Savant Wealth Management Investment Advisor 0.0577 1667 0 2022-12-31 LOW
WMS Partners LLC Investment Advisor 0.0577 1667 0 2022-12-31 MED
Money Concepts Capital Corp Investment Advisor 0.0555 1603 420 2022-12-31 HIGH
Zeldis (Jerome B) Individual Investor 0.0529 1528 0 2023-01-05 LOW
Two Sigma Investments, LP Hedge Fund 0.0502 1451 1451 2022-12-31 HIGH

Hvorfor vælge Capital.com? Vores tal taler for sig selv.

Capital.com Group

500K+

Handlende

92K+

Månedlkige, aktive klienter

$53M+

Månedlig investeringsvolumen

$30M+

Hævet hver måned

Handelslommeregner

Udregn dit hypotetiske P&L hvis du havde åbnet en CFD-handel på en given dato (vælg en dato) og lukket den på en anden dato (vælg en dato).

Handelskurtage
0
  • 1:1
Gearing
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investering
Handelsstørrelse (Gearing x Investering):
Åben

Luk

Short Long

Soligenix, Inc. Company profile

Om Soligenix, Inc.

Soligenix, Inc. er en biofarmaceutisk virksomhed i den sene fase. Virksomheden fokuserer på at udvikle produkter til behandling af sjældne sygdomme. Virksomheden opererer gennem to segmenter: Specialized BioTherapeutics og Public Health Solutions. Specialized BioTherapeutics segmenter omfatter udvikling af HyBryte (SGX301 eller syntetisk hypericin), en fotodynamisk terapi til behandling af kutant T-celle lymfom (CTCL). Segmentet Public Health Solutions omfatter RiVax til beskyttelse mod eksponering for ricin-toksinvaccinkandidat og SGX943 terapeutisk kandidat til behandling af antibiotikaresistente og infektiøse sygdomme. Selskabets udviklingsprogrammer omfatter IDR-teknologi (innate defense regulator), dusquetide (SGX942) til behandling af inflammatoriske sygdomme, oral mucositis i forbindelse med hoved- og halskræft og oral beclomethason 17,21-dipropionat (BDP) til forebyggelse/behandling af gastrointestinale (GI) lidelser, herunder pædiatrisk Crohns sygdom (SGX203).

Industry: Bio Therapeutic Drugs

Suite C-10
29 Emmons Drive
08540

Resultatopgørelse

  • Annual
  • Quarterly

Folk ser også

Oil - Crude

75.76 Price
+1.830% 1D Chg, %
Long position, gebyr natten over -0.0156%
Short position, gebyr natten over -0.0063%
Gebyr natten over, tid 21:00 (UTC)
Spænd 0.03

US100

13,186.80 Price
+1.680% 1D Chg, %
Long position, gebyr natten over -0.0249%
Short position, gebyr natten over 0.0027%
Gebyr natten over, tid 21:00 (UTC)
Spænd 3.0

Gold

1,969.66 Price
-0.550% 1D Chg, %
Long position, gebyr natten over -0.0185%
Short position, gebyr natten over 0.0102%
Gebyr natten over, tid 21:00 (UTC)
Spænd 0.30

BTC/USD

28,470.15 Price
+0.160% 1D Chg, %
Long position, gebyr natten over -0.0616%
Short position, gebyr natten over 0.0137%
Gebyr natten over, tid 21:00 (UTC)
Spænd 60.00

Leder du stadig efter en mægler, du kan stole på?

Deltag sammen med 500.000+ handlende over hele verden, der valgte at handle hos Capital.com

1. Opret og bekræft din konto 2. Lav en inddbetaling 3. Find din handel